fluorodopa f 18 has been researched along with Sensitivity and Specificity in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.44) | 18.2507 |
2000's | 37 (45.12) | 29.6817 |
2010's | 41 (50.00) | 24.3611 |
2020's | 2 (2.44) | 2.80 |
Authors | Studies |
---|---|
Bund, C; Cebula, H; Chibbaro, S; Lefebvre, F; Lhermitte, B; Namer, IJ; Pin, Y; Proust, F; Todeschi, J | 1 |
Barachini, O; Bernt, R; Hergan, K; Mirzaei, S; Pirich, C; Zandieh, S | 1 |
Brouwers, AH; de Groot, DJA; Noordzij, W; Veenstra, EB; Walenkamp, AME | 1 |
Cuny, T; Ginet, M; Marie, PY; Schmitt, E; Verger, A | 1 |
Borson-Chazot, F; Bournaud, C; Combemale, P; Giammarile, F; Giraudet, AL; Houzard, C; Kryza, D; Lifante, JC; Mognetti, T; Moreau, A | 1 |
Brinkmann, DH; Giannini, C; Hunt, CH; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Youland, RS | 1 |
Göllner, A; Hacker, M; Hartenbach, M; Hartenbach, S; Karanikas, G; Mayerhoefer, M; Mazal, P; Rasul, S; Rebhan, K | 1 |
Bodner, G; Brammen, L; Karanikas, G; Koperek, O; Niederle, B; Niederle, MB; Riss, P; Scheuba, C; Selberherr, A | 1 |
Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E | 1 |
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
Bal, C; Bandopadhyaya, GP; Goenka, A; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
Benard, F; Chan, EK; Cheung, A; Hsu, F; Kosztyla, R; Ma, R; Moiseenko, V; Nichol, A; Wilson, D; Zhang, S | 1 |
Allen-Auerbach, M; Chen, W; Czernin, J; DeSalles, AA; Lizarraga, KJ; Phelps, ME; Yong, WH | 1 |
Bal, C; Ballal, S; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Sharma, P | 1 |
Goedicke, A; Kops, ER; Mottaghy, FM; Rong, Y; Vernaleken, I; Winz, OH | 1 |
Bozzao, A; Cicone, F; Maurizi Enrici, R; Minniti, G; Papa, A; Romano, A; Scaringi, C; Scopinaro, F; Tavanti, F | 1 |
Benisvy, D; Darcourt, J; Dufour, M; Fontana, X; Koulibaly, PM; Ouvrier, MJ; Sapin, N; Schiazza, A | 1 |
Knie, B; Moskopp, D; Plotkin, M; Prasad, V; Zschieschang, P | 1 |
Dudczak, R; El-Rabadi, K; Hacker, M; Karanikas, G; Mayerhofer, M; Mitterhauser, M; Nakuz, T; Scherer, T; Weber, M | 1 |
Bozzao, A; Cicone, F; Mancuso, V; Minniti, G; Napolitano, A; Romano, A; Rossi Espagnet, MC; Scaringi, C | 1 |
Boisson, F; Brasse, D; Detour, J; Imperiale, A; Kessler, L; Kreutter, G; Lavaux, T; Marchand, P; Namer, IJ; Pierre, A | 1 |
Ito, T; Jensen, RT | 1 |
Chen, W; Cloughesy, T; Czernin, J; Freitas, B; Ledezma, CJ; Pope, W; Sai, V | 1 |
Bose, SK; Cunliffe, R; Grasby, PM; Howes, OD; Mehta, MA; Stokes, PR; Turkheimer, FE | 1 |
Dierckx, RA; Eshuis, SA; Jager, PL; Jonkman, S; Leenders, KL; Maguire, RP | 1 |
Auernhammer, CJ; Bartenstein, P; Göke, B; Haug, A; Pöpperl, G; Schmidt, G; Tiling, R; Wängler, B | 1 |
Beheshti, M; Broinger, G; Dralle, H; Kohlfürst, S; Langsteger, W; Nader, M; Pirich, C; Pöcher, S; Vali, R; Waldenberger, P | 1 |
Agopian, VG; Auerbach, MS; Benz, MR; Czernin, JG; Dumont, RA; Imani, F; Lai, CK; Walter, MA; Yeh, MW | 1 |
Brouwers, AH; de Jong, JR; de Vries, EG; Dierckx, RA; Elsinga, PH; Fiebrich, HB; Jager, PL; Kema, IP; Kerstens, MN; Links, TP; Pijl, ME; Sluiter, WJ; van der Wal, JE | 1 |
Dollé, F; Ducongé, F; Gombert, K; Kuhnast, B; Le Helleix, S; Pestourie, C; Tavitian, B; Thézé, B | 1 |
Ambrosini, V; Fanti, S; Marzola, MC; Rubello, D | 1 |
Aigrain, Y; Brunelle, F; Capito, C; Crétolle, C; De Lonlay, P; Jaubert, F; Khen-Dunlop, N; Nihoul-Fékété, C; Ribeiro, MJ | 1 |
Buck, AK; Dralle, H; Glatting, G; Karges, W; Luster, M; Mottaghy, FM; Neumaier, B; Pauls, S; Reske, SN; Solbach, C; Verburg, FA; Zeich, K | 1 |
Cavet, M; Dousset, B; Faraggi, M; Hignette, C; Modis, C; Richard, B; Tenenbaum, F | 1 |
Carrasquillo, JA; Chen, CC; Chowdhury, I; Gharib, AM; Gundabolu, B; Nieman, LK; Sinaii, N; Whatley, M; Zemskova, MS | 1 |
Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A | 1 |
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
Bauerfeind, P; Clavien, PA; Hany, T; Muller, MK; Schiesser, M; Veit-Haibach, P; Weber, M | 1 |
Clavien, PA; Hany, TF; Hesselmann, R; Schaefer, NG; Schiesser, M; Soyka, J; Strobel, K; Veit-Haibach, P | 1 |
Schwarz, J | 1 |
Bourgeat, P; Coulthard, A; Crozier, S; Daglish, M; Dowson, N; Fay, M; MacFarlane, D; Rose, S; Salvado, O; Smith, J; Thomas, P; Winter, C | 1 |
Endres, CJ; Hayashi, T; Iida, H; Kumakura, Y; Matsubara, K; Minato, K; Watabe, H | 1 |
Doi, R; Fukuyama, S; Kasai, T; Masue, M; Nishibori, H; Okamoto, S; Tokumi, T; Uemoto, S; Yorifuji, T; Yoshizawa, A | 1 |
Chen, X; Cleary, S; Dawson, LF; Eisenhofer, G; Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Pacak, K; Phillips, JK; Powers, JF; Seidel, J; Thomasson, D | 1 |
Chirakal, R; Gulenchyn, KY; Jager, PL; Major, P; Reid, R; Yakemchuk, VN | 1 |
Altrinetti, V; Chiti, A; Cistaro, A; Fanti, S; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Villavecchia, G | 1 |
Calabria, F; Chiaravalloti, A; Di Pietro, B; Grasso, C; Schillaci, O | 1 |
Cocciolillo, F; de Waure, C; Di Nardo, F; Giordano, A; Poscia, A; Rufini, V; Treglia, G | 1 |
Giordano, A; Mirk, P; Rufini, V; Treglia, G | 1 |
Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL | 1 |
Bartsch, O; Fottner, C; Helisch, A; Lackner, KJ; Mann, WJ; Miederer, M; Musholt, TJ; Papaspyrou, K; Rossmann, H; Schreckenberger, M; Weber, MM | 1 |
Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Moser, E; Neumann, HP; Schipper, J | 1 |
Cheng, CY; Chiang, YH; Chou, YH; Huang, WS; Lin, JC; Liu, RS | 1 |
Aide, N; Balogova, S; Colombet, C; De Beco, V; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N | 1 |
Pirker, W | 1 |
Asenbaum, S; Becherer, A; Czech, T; Henk, C; Karanikas, G; Kletter, K; Marosi, C; Szabó, M; Wadsak, W; Wunderbaldinger, P; Zettinig, G | 1 |
Heiss, WD; Hilker, R | 1 |
Bailey, DL; Brooks, DJ; Pavese, N; Remy, P; Whone, AL | 1 |
Angelberger, P; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Raderer, M; Szabó, M; Wunderbaldinger, P | 1 |
Biraben, A; Bouilleret, V; Chassoux, F; Ribeiro, MJ; Semah, F; Syrota, A; Taussig, D | 1 |
Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
Christensen, S; Cumming, P; Danielsen, EH; Gjedde, A; Kumakura, Y | 1 |
Declerck, JM; Leong, FJ; McLaughlin, RA; Pan, XB; Silverman, DH; Wright, TG | 1 |
Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Kamdar, N; Pope, W; Satyamurthy, N; Schiepers, C; Silverman, DH | 1 |
Ametamey, SM; Blagoev, M; Hengerer, B; Hintermann, S; Honer, M; Schubiger, PA; Waldmeier, P | 1 |
Fanti, S; Nanni, C; Rubello, D | 1 |
Aide, N; de Beco, V; Grahek, D; Grangé, JD; Gutman, F; Kerrou, K; Lotz, JP; Montravers, F; Ruszniewski, P; Talbot, JN | 1 |
Sperling, MA | 1 |
Adzick, NS; Alavi, A; Freifelder, R; Ganguly, A; Hardy, OT; Hernandez-Pampaloni, M; Ruchelli, E; Saffer, JR; Stanley, CA; Suchi, M; Zhuang, H | 1 |
Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J | 1 |
Al-Nahhas, A; Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Montini, G; Nanni, C; Rubello, D; Tomassetti, P | 1 |
Bellanné-Chantelot, C; Boddaert, N; Bourgeois, S; Brunelle, F; De Lonlay, P; Delzescaux, T; Jaubert, F; Nihoul-Fékété, C; Ribeiro, MJ; Valayannopoulos, V | 1 |
Biraben, A; Bouilleret, V; Chassoux, F; Mantzaridez, M; Ribeiro, MJ; Semah, F; Trebossen, R | 1 |
Al-Nahhas, A; Ambrosini, V; Fanti, S; Nanni, C; Rubello, D | 1 |
Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Franchi, R; Montini, G; Nanni, C; Rizzello, A; Rubello, D; Tomassetti, P | 1 |
Belakhlef, A; Chaly, T; Dahl, R; Dhawan, V; Eidelberg, D; Ishikawa, T; Mandel, F; Margouleff, C; Robeson, W | 1 |
Bailey, DL; Brooks, DJ; Morrish, PK; Rakshi, JS; Sawle, GV | 1 |
Morrish, PK | 1 |
Burger, C; Dimitrakopoulou-Strauss, A; Strauss, LG | 1 |
Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Manz, T; Moser, E; Neumann, HP; Nitzsche, E; Reincke, M | 1 |
Angelberger, P; Füchtner, F; Hammerschmidt, F; Kvaternik, H; Simovc, BP; Steinbach, J | 1 |
9 review(s) available for fluorodopa f 18 and Sensitivity and Specificity
Article | Year |
---|---|
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
18F-FDOPA PET for the diagnosis of parkinsonian syndromes.
Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Humans; Image Processing, Computer-Assisted; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2014 |
Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.
Topics: Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Glucagon-Like Peptide 1; Humans; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2010 |
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Evidence-Based Medicine; Humans; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2012 |
The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease.
Topics: Brain; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression; Humans; Magnetic Resonance Imaging; Parkinson Disease; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
15 trial(s) available for fluorodopa f 18 and Sensitivity and Specificity
Article | Year |
---|---|
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Young Adult | 2018 |
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.
Topics: Child; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neuroblastoma; Neuroendocrine Tumors; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18F-DOPA positron emission tomography for the detection of glomus tumours.
Topics: Adult; Aged; Carotid Body Tumor; Dihydroxyphenylalanine; Female; Glomus Tumor; Humans; Male; Middle Aged; Paraganglioma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
Topics: Aged; Corpus Striatum; Cross-Over Studies; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Parkinson Disease; Putamen; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tropanes | 2003 |
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.
Topics: Adult; Aged; Carcinoma, Small Cell; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
Topics: Algorithms; Antiparkinson Agents; Canada; Dihydroxyphenylalanine; Dopamine Agents; France; Germany; Humans; Image Interpretation, Computer-Assisted; Indoles; Levodopa; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; United Kingdom | 2004 |
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis.
Topics: Adult; Algorithms; Anticonvulsants; Basal Ganglia; Brain Mapping; Dihydroxyphenylalanine; Drug Resistance; Epilepsy; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Topics: Aged; Brain; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Functional Laterality; Humans; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Reference Values; Sensitivity and Specificity; Time Factors | 2006 |
Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's disease.
Topics: Brain; Brain Mapping; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tissue Distribution | 2005 |
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Topics: Adult; Aged; Brain Neoplasms; California; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Digestive System Neoplasms; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed; Ultrasonography | 2007 |
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
Topics: Adolescent; Adult; Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra | 2008 |
58 other study(ies) available for fluorodopa f 18 and Sensitivity and Specificity
Article | Year |
---|---|
Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Robotics; Sensitivity and Specificity; Stereotaxic Techniques; Young Adult | 2019 |
The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Tensor Imaging; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
18F-FDOPA PET Imaging in Prolactinoma.
Topics: Dihydroxyphenylalanine; Humans; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Sensitivity and Specificity | 2017 |
Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Treatment Outcome | 2017 |
[
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2018 |
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Neuroendocrine; Child; Clinical Decision-Making; Dihydroxyphenylalanine; False Negative Reactions; False Positive Reactions; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tumor Burden; Ultrasonography; Young Adult | 2018 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
Topics: Adult; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden; Young Adult | 2013 |
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiation Injuries; Radiotherapy; Recurrence; Sensitivity and Specificity; Young Adult | 2014 |
Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Glioma; Humans; India; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Simulation-based partial volume correction for dopaminergic PET imaging: Impact of segmentation accuracy.
Topics: Artifacts; Brain; Computer Simulation; Dihydroxyphenylalanine; Dopamine; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Biological; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Postoperative Period; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
A family with pheochromocytoma-paraganglioma inherited tumour syndrome. Serial 18F-DOPA PET/CT investigations.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neoplastic Syndromes, Hereditary; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Negative Reactions; Female; Humans; Male; Middle Aged; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2016 |
Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Topics: Animals; Carbidopa; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Image Enhancement; Insulinoma; Metabolic Clearance Rate; Mice, Nude; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2017 |
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.
Topics: Adult; Aged; Brain; Control Groups; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neural Networks, Computer; Positron-Emission Tomography; Schizophrenia, Paranoid; Sensitivity and Specificity | 2008 |
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
Topics: Adult; Aged; Brain; Case-Control Studies; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sex Characteristics; Tomography, Emission-Computed, Single-Photon; Tropanes | 2009 |
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Serotonin | 2009 |
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine exces
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Biomarkers; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Neoplasia Type 2a; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2010 |
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Thyroid Gland; Thyroid Neoplasms | 2010 |
Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Diagnostic Errors; Dihydroxyphenylalanine; Female; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric | 2009 |
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.
Topics: Adolescent; Adult; Aged; Biological Transport; Child; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2010 |
[Recurrent carcinoid tumor and 18F-DOPA PET].
Topics: Biomarkers, Tumor; Carcinoid Tumor; Colonic Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2010 |
Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.
Topics: ACTH Syndrome, Ectopic; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Indium Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Somatostatin; Thoracic Neoplasms | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy | 2010 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed | 2010 |
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Dihydroxyphenylalanine; Female; Humans; Iohexol; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2011 |
Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patients.
Topics: Algorithms; Brain Neoplasms; Computer Simulation; Dihydroxyphenylalanine; Factor Analysis, Statistical; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway.
Topics: Animals; Brain; Dihydroxyphenylalanine; Dopamine; Levodopa; Linear Models; Macaca fascicularis; Models, Neurological; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
Topics: Asian People; Child, Preschool; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Infant; Japan; Pancreas; Pancreatectomy; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Female; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Neoplasms, Experimental; Norepinephrine Plasma Membrane Transport Proteins; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins | 2012 |
PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
Topics: Adult; Aged; Aged, 80 and over; Canada; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Intestinal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2012 |
Characterization of neuroblastic tumors using 18F-FDOPA PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid | 2013 |
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET.
Topics: Adolescent; Adult; Child; Dihydroxyphenylalanine; False Negative Reactions; Female; Germ-Line Mutation; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Sensitivity and Specificity; Succinate Dehydrogenase; Syndrome; Young Adult | 2013 |
Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Topics: Activities of Daily Living; Aged; Brain; Cocaine; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Neural Pathways; Neurologic Examination; Parkinson Disease; Sensitivity and Specificity; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Nortropanes; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Substantia Nigra; Synaptic Transmission; Tyrosine | 2006 |
18F-DOPA PET/CT and neuroendocrine tumours.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
Topics: Adult; Aged; Carcinoid Tumor; Digestive System Neoplasms; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Somatostatin | 2006 |
PET scanning for infants with HHI: a small step for affected infants, a giant leap for the field.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity | 2007 |
Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
Topics: Confidence Intervals; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Pancreas; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2007 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients.
Topics: Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.
Topics: Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
Topics: Adult; Aged; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Humans; Kinetics; Male; Middle Aged; Nitriles; Occipital Lobe; Parkinson Disease; Quality Control; Sensitivity and Specificity; Tomography, Emission-Computed; Tyrosine | 1996 |
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Topics: Aged; Case-Control Studies; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Humans; Linear Models; Middle Aged; Parkinson Disease; Prospective Studies; Putamen; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed | 1998 |
Parkinson's disease in twins.
Topics: Dihydroxyphenylalanine; Diseases in Twins; False Negative Reactions; False Positive Reactions; Humans; Parkinson Disease; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Models, Theoretical; Oxygen Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Pheochromocytoma; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Aspects of 6-[18F]fluoro-L-DOPA preparation: precursor synthesis, preparative HPLC purification and determination of radiochemical purity.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Models, Chemical; Quality Control; Radiopharmaceuticals; Sensitivity and Specificity | 2002 |